New JACC Publication Reinforces Value of a Coronary CTA + HeartFlow Analysis-Guided Pathway for Diagnosing Heart Disease
Summary
The PACIFIC study included 208 patients who each underwent a coronary CTA, SPECT, PET and three-vessel invasive fractional flow reserve (FFR) measurements. On a per-vessel basis, HeartFlow demonstrated significantly greater diagnostic performance (0.94 as measured by area under the receiver operating characteristic curve) compared to coronary CTA (0.83, p<0.001), SPECT (0.70, p<0.001) and PET (0.87, p<0.001). More and more centers around the world are incorporating a coronary CTA and HeartFlow Analysis-guided pathway into their clinical workflow as physicians appreciate having highly accurate and actionable information to ensure their patients receive the best possible care.” The HeartFlow Analysis leverages artificial intelligence and highly trained analysts to create a digital 3D model of the patient’s arteries using image data taken from a standard CTA. The HeartFlow technology has been demonstrated to reduce unnecessary invasive diagnostic coronary angiography procedures, which can be associated with bleeding, stroke, major blood vessel damage and other serious complications.